Imatinib Completed Phase 2 Trials for Leukemia, Myeloid, Chronic-Phase Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00048672Therapy of Early Chronic Phase CML With Gleevec